- Home
- Publications
- Publication Search
- Publication Details
Title
The SWI/SNF complex in cancer — biology, biomarkers and therapy
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-17
DOI
10.1038/s41571-020-0357-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Translational genomics of malignant rhabdoid tumours: Current impact and future possibilities
- (2020) Martina A. Finetti et al. SEMINARS IN CANCER BIOLOGY
- Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer
- (2019) Young-Bae Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment
- (2019) Zhongyi Hu et al. Nature Communications
- CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary
- (2019) Yibo Xue et al. Nature Communications
- SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer
- (2019) Yibo Xue et al. Nature Communications
- Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
- (2019) Helai P. Mohammad et al. NATURE MEDICINE
- Genomic correlates of response to immune checkpoint blockade
- (2019) Tanya E. Keenan et al. NATURE MEDICINE
- A Phase 2 Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase 1 and Pilot Consortium ADVL0921)
- (2019) Yael P. Mosse et al. CLINICAL CANCER RESEARCH
- MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors
- (2019) Thomas P Howard et al. CANCER RESEARCH
- SWI/SNF-compromised cancers are susceptible to bromodomain inhibitors
- (2019) Tatiana Shorstova et al. CANCER RESEARCH
- p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors
- (2019) Alessandro Carugo et al. CANCER CELL
- Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities
- (2019) Krystal A Orlando et al. Expert Review of Anticancer Therapy
- BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors
- (2019) Xiaofeng Wang et al. Nature Communications
- Loss of ARID1A in tumor cells renders selective vulnerability to combined ionizing radiation and PARP inhibitor therapy
- (2019) Youngran Park et al. CLINICAL CANCER RESEARCH
- BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
- (2019) William Farnaby et al. Nature Chemical Biology
- Inhibition of MYC by the SMARCB1 tumor suppressor
- (2019) April M. Weissmiller et al. Nature Communications
- Prognostic role of ARID1A negative expression in gastric cancer
- (2019) Mai Ashizawa et al. Scientific Reports
- Systematic characterization of BAF mutations provides insights into intracomplex synthetic lethalities in human cancers
- (2019) Sandra Schick et al. NATURE GENETICS
- The genetic alteration spectrum of the SWI/SNF complex: The oncogenic roles of BRD9 and ACTL6A
- (2019) Xiaoxian Sima et al. PLoS One
- Exploiting epigenetic vulnerabilities in solid tumors: novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers
- (2019) Roman M. Chabanon et al. SEMINARS IN CANCER BIOLOGY
- Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid Tumors
- (2019) Elaine M. Oberlick et al. Cell Reports
- ARID1A promotes genomic stability through protecting telomere cohesion
- (2019) Bo Zhao et al. Nature Communications
- Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration
- (2019) Hye-Jung E. Chun et al. Cell Reports
- Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors
- (2019) Amaury Leruste et al. CANCER CELL
- Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus
- (2019) Ben Ho et al. NEURO-ONCOLOGY
- The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma
- (2018) Matthew J. McBride et al. CANCER CELL
- Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition
- (2018) Jessica D. Lang et al. CLINICAL CANCER RESEARCH
- The SWI/SNF complex subunit genes: Their functions, variations, and links to risk and survival outcomes in human cancers
- (2018) Sevtap Savas et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes
- (2018) Aktan Alpsoy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade
- (2018) Petar Jelinic et al. JNCI-Journal of the National Cancer Institute
- Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
- (2018) Antoine Italiano et al. LANCET ONCOLOGY
- ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade
- (2018) Jianfeng Shen et al. NATURE MEDICINE
- Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
- (2018) David F. McDermott et al. NATURE MEDICINE
- A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
- (2018) Deng Pan et al. SCIENCE
- Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
- (2018) Diana Miao et al. SCIENCE
- Hereditary SWI/SNF complex deficiency syndromes
- (2018) Abbas Agaimy et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- Repurposing Pan-HDAC Inhibitors for ARID1A -Mutated Ovarian Cancer
- (2018) Takeshi Fukumoto et al. Cell Reports
- Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade
- (2018) Petar Jelinic et al. JNCI-Journal of the National Cancer Institute
- The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression
- (2018) Simonetta Buglioni et al. OncoImmunology
- Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1 deficient Group 2 Atypical Teratoid Rhabdoid Tumors to suppress tumor growth in vivo
- (2018) Irina Alimova et al. INTERNATIONAL JOURNAL OF CANCER
- Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation
- (2018) Serap Erkek et al. CANCER CELL
- Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes
- (2018) Nazar Mashtalir et al. CELL
- Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer
- (2018) Yufeng Ding et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers
- (2018) Julien P. N. Papillon et al. JOURNAL OF MEDICINAL CHEMISTRY
- A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation
- (2018) Brittany C. Michel et al. NATURE CELL BIOLOGY
- A non-canonical BRD9-containing BAF chromatin remodeling complex regulates naive pluripotency in mouse embryonic stem cells
- (2018) Jovylyn Gatchalian et al. Nature Communications
- Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma
- (2018) Gerard L Brien et al. eLife
- SWI/SNF complex in cancer
- (2017) Chao Lu et al. NATURE GENETICS
- SMARCB1 is required for widespread BAF complex–mediated activation of enhancers and bivalent promoters
- (2017) Robert T Nakayama et al. NATURE GENETICS
- Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers
- (2017) H. Courtney Hodges et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness
- (2017) Benedikt Kaufmann et al. PLoS One
- SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers
- (2017) Vural Tagal et al. Nature Communications
- The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers
- (2017) Burak H. Alver et al. Nature Communications
- Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade
- (2017) Yi-Feng Gu et al. Cancer Discovery
- Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers
- (2017) H. Courtney Hodges et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- High-Throughput Drug Screening Identifies Pazopanib and Clofilium Tosylate as Promising Treatments for Malignant Rhabdoid Tumors
- (2017) Céline Chauvin et al. Cell Reports
- Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
- (2016) Jonathon Torchia et al. CANCER CELL
- Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes
- (2016) Pascal D. Johann et al. CANCER CELL
- Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways
- (2016) Hye-Jung E. Chun et al. CANCER CELL
- Synthetic Lethal Targeting of ARID1A -Mutant Ovarian Clear Cell Tumors with Dasatinib
- (2016) Rowan E. Miller et al. MOLECULAR CANCER THERAPEUTICS
- Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
- (2016) Anja F Hohmann et al. Nature Chemical Biology
- Dynamics of BAF–Polycomb complex opposition on heterochromatin in normal and oncogenic states
- (2016) Cigall Kadoch et al. NATURE GENETICS
- SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation
- (2016) Xiaofeng Wang et al. NATURE GENETICS
- ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice
- (2016) Radhika Mathur et al. NATURE GENETICS
- The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis
- (2016) William J Gibson et al. NATURE GENETICS
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- Stop pulling my strings — what telomeres taught us about the DNA damage response
- (2016) Eros Lazzerini-Denchi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program
- (2016) Raushan T. Kurmasheva et al. PEDIATRIC BLOOD & CANCER
- Mismatch Repair and Colon Cancer: Mechanisms and Therapies Explored
- (2016) Stephen K.H. Li et al. TRENDS IN MOLECULAR MEDICINE
- The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation
- (2016) Zhi-Yan Han et al. Nature Communications
- ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A
- (2016) Chris T. Williamson et al. Nature Communications
- LncBRM initiates YAP1 signalling activation to drive self-renewal of liver cancer stem cells
- (2016) Pingping Zhu et al. Nature Communications
- Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors
- (2016) Jocelyn P. Wong et al. Cell Reports
- The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer
- (2016) Courtney Hodges et al. Cold Spring Harbor Perspectives in Medicine
- A pan-cancer analysis of prognostic genes
- (2016) Jordan Anaya et al. PeerJ
- Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma
- (2016) Satoshi Kawano et al. PLoS One
- Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
- (2015) Michael Zengerle et al. ACS Chemical Biology
- Somatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5 +/− leukemia
- (2015) Louise van der Weyden et al. BMC CANCER
- Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
- (2015) Jing Lu et al. CHEMISTRY & BIOLOGY
- Drugging PI3K in cancer: refining targets and therapeutic strategies
- (2015) Timothy A Yap et al. CURRENT OPINION IN PHARMACOLOGY
- The SWI/SNF chromatin remodelling complex: Its role in maintaining genome stability and preventing tumourigenesis
- (2015) Peter M. Brownlee et al. DNA REPAIR
- Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition
- (2015) Natalie H. Theodoulou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type
- (2015) Anthony N Karnezis et al. JOURNAL OF PATHOLOGY
- The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias
- (2015) Anna K Andersson et al. NATURE GENETICS
- SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2
- (2015) Kimberly H Kim et al. NATURE MEDICINE
- Phthalimide conjugation as a strategy for in vivo target protein degradation
- (2015) G. E. Winter et al. SCIENCE
- ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
- (2015) J. Shen et al. Cancer Discovery
- Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes
- (2015) Jesse R. Raab et al. PLoS Genetics
- The silencing of the SWI/SNF subunit and anticancer gene BRM in Rhabdoid tumors
- (2015) Bhaskar Kahali et al. Oncotarget
- Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition
- (2015) Eleftherios P. Samartzis et al. Oncotarget
- SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis
- (2014) Martin Hasselblatt et al. ACTA NEUROPATHOLOGICA
- SWI/SNF Factors Required for Cellular Resistance to DNA Damage Include ARID1A and ARID1B and Show Interdependent Protein Stability
- (2014) R. Watanabe et al. CANCER RESEARCH
- ConsistentSMARCB1homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material
- (2014) Francois Le Loarer et al. GENES CHROMOSOMES & CANCER
- ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder
- (2014) Sheila F. Faraj et al. HUMAN PATHOLOGY
- BRG1 promotes the repair of DNA double-strand breaks by facilitating the replacement of RPA with RAD51
- (2014) W. Qi et al. JOURNAL OF CELL SCIENCE
- Requirement for PBAF in Transcriptional Repression and Repair at DNA Breaks in Actively Transcribed Regions of Chromatin
- (2014) Andreas Kakarougkas et al. MOLECULAR CELL
- Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4
- (2014) Pilar Ramos et al. NATURE GENETICS
- ARID1B is a specific vulnerability in ARID1A-mutant cancers
- (2014) Katherine C Helming et al. NATURE MEDICINE
- Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers
- (2014) G. R. Hoffman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes
- (2014) Robert Huether et al. Nature Communications
- SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors
- (2014) Miriam J. Smith et al. Cancer Genetics
- BAF180 Promotes Cohesion and Prevents Genome Instability and Aneuploidy
- (2014) Peter M. Brownlee et al. Cell Reports
- A Synthetic Lethality-Based Strategy to Treat Cancers Harboring a Genetic Deficiency in the Chromatin Remodeling Factor BRG1
- (2013) T. Oike et al. CANCER RESEARCH
- Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial Sarcoma
- (2013) Cigall Kadoch et al. CELL
- Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer
- (2013) Hanbyoul Cho et al. HUMAN PATHOLOGY
- Extracranial rhabdoid tumours: what we have learned so far and future directions
- (2013) Bernadette Brennan et al. LANCET ONCOLOGY
- Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer
- (2013) Tjalling Bosse et al. MODERN PATHOLOGY
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- BAF complexes facilitate decatenation of DNA by topoisomerase IIα
- (2013) Emily C. Dykhuizen et al. NATURE
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
- (2013) Cigall Kadoch et al. NATURE GENETICS
- BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer
- (2013) Jin Bai et al. PLoS One
- The Spectrum of SWI/SNF Mutations, Ubiquitous in Human Cancers
- (2013) A. Hunter Shain et al. PLoS One
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
- (2013) S. K. Knutson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of SMARCB1 (INI1) mutations in familial schwannomatosis
- (2012) M. J. Smith et al. HUMAN MOLECULAR GENETICS
- SWI/SNF Chromatin-remodeling Factors: Multiscale Analyses and Diverse Functions
- (2012) Ghia Euskirchen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers
- (2012) Ryan S. Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells
- (2012) Sujatha Venkataraman et al. JOURNAL OF NEURO-ONCOLOGY
- Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma
- (2012) Mio Endo et al. LIVER INTERNATIONAL
- A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
- (2012) Sarah K Knutson et al. Nature Chemical Biology
- Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome
- (2012) Jeroen K J Van Houdt et al. NATURE GENETICS
- Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome
- (2012) Yoshinori Tsurusaki et al. NATURE GENETICS
- Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
- (2012) Panagiotis Ntziachristos et al. NATURE MEDICINE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Mutations in EZH2 Cause Weaver Syndrome
- (2011) William T. Gibson et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor
- (2011) F. Bourdeaut et al. CLINICAL CANCER RESEARCH
- Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas
- (2011) Marco Dal Molin et al. HUMAN PATHOLOGY
- TCR-dependent transformation of mature memory phenotype T cells in mice
- (2011) Xi Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
- (2011) Ignacio Varela et al. NATURE
- Histone deacetylase inhibition decreases proliferation and potentiates the effect of ionizing radiation in atypical teratoid/rhabdoid tumor cells
- (2011) J. A. Knipstein et al. NEURO-ONCOLOGY
- Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI/SNF chromatin remodeling and the recruitment of non-homologous end joining factors
- (2011) H Ogiwara et al. ONCOGENE
- PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma
- (2011) Sohei Yamamoto et al. VIRCHOWS ARCHIV
- Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation
- (2010) Boris G. Wilson et al. CANCER CELL
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway
- (2010) Zainab Jagani et al. NATURE MEDICINE
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- The Biology of Chromatin Remodeling Complexes
- (2009) Cedric R. Clapier et al. Annual Review of Biochemistry
- Oncogenesis Caused by Loss of the SNF5 Tumor Suppressor Is Dependent on Activity of BRG1, the ATPase of the SWI/SNF Chromatin Remodeling Complex
- (2009) X. Wang et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now